Seasonal Differences in Home Dialysis Uptake and Initiating Dialysis in the Hospital
NCT ID: NCT04935827
Last Updated: 2021-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
400000 participants
OBSERVATIONAL
2007-12-01
2017-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of On-Line Hemodiafiltration(HDF) on Vascular Health in Chronic Hemodialysis Patients
NCT00532597
Prevalence of Non-adherence to Medication Among Patients on Chronic Hemodialysis
NCT03897231
Effects of Daily Home Hemodialysis on Circulation, Mental Functions, and Quality of Life
NCT00150956
Transitioning to Home or In-center Dialysis
NCT05989659
Cessation of Dialysis Treatment in Reinbek and Geesthacht
NCT03820765
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients initiating dialysis for end-stage kidney disease
Patients whose start of dialysis is from 12/1/2007-11/30/2017. We use the following inclusion criteria:
* Adult (\>= 18 years old)
* Did not die or have a transplant prior to the 90th day of dialysis
* Valid medical evidence form
* Medicare Part A/B as primary payer in the 30 days prior to initiating dialysis
* Initiating dialysis in the USA
Season of Year
We stratify patients into 4 groups based on the season of the year (between 12/1/2007-11/30/2017)
* Winter: December, January, February
* Spring: March, April, May
* Summer: June, July, August
* Fall: September, October, November
Hospitalized 14 days prior to dialysis
We further stratify patients into 3 groups based on whether they were hospitalized within 14 days prior to dialysis
* Group 1: No hospitalization prior to dialysis
* Group 2: Hospitalized within 14 days prior to dialysis for an acute infectious respiratory condition or one of the following acute cardiac conditions (arrhythmia, myocardial infarction, stroke, or fluid overload)
* Group 3: Hospitalized within 14 days prior to dialysis for a condition not in Group 2
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Season of Year
We stratify patients into 4 groups based on the season of the year (between 12/1/2007-11/30/2017)
* Winter: December, January, February
* Spring: March, April, May
* Summer: June, July, August
* Fall: September, October, November
Hospitalized 14 days prior to dialysis
We further stratify patients into 3 groups based on whether they were hospitalized within 14 days prior to dialysis
* Group 1: No hospitalization prior to dialysis
* Group 2: Hospitalized within 14 days prior to dialysis for an acute infectious respiratory condition or one of the following acute cardiac conditions (arrhythmia, myocardial infarction, stroke, or fluid overload)
* Group 3: Hospitalized within 14 days prior to dialysis for a condition not in Group 2
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No transplant or death prior to day 90 of dialysis
* Medicare Parts A/B as primary payer 30 days prior to starting dialysis
* Valid Medicare Evidence Form (Form 2728)
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
University of Southern California
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eugene Lin
Assistant Professor
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HS-18-00530-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.